SELECTION OF COLORECTAL CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY

摘要

Methods using mass spectral data analysis and a classification algorithm provide an ability to determine whether a colorectal cancer (CRC) patient is likely to benefit from a drug targeting an epidermal growth factor receptor pathway, such as monoclonal antibody EGFR inhibitors.